Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
WHO recommends Roche, Sanofi/Regeneron drugs as COVID-19 treatments, calls for lower prices
07:48am, Wednesday, 07'th Jul 2021
The World Health Organization began recommending the use of medicines called interleukin-6 receptor blockers as COVID-19 treatments for the severely ill, based on the findings of a large clinical stud
As Sanofi launches its Covid vaccine by December, should you invest now?
07:29am, Wednesday, 07'th Jul 2021
French pharmaceutical giant Sanofi SA (LON:0O59) said Monday its Covid-19 vaccine developed in partnership with UK Pharma GlaxoSmithKline Plc (NYSE:GSK) could be ready for roll-out by December. Sanofi
102 'Top Dividend Stocks On Earth' July Update
07:04am, Sunday, 04'th Jul 2021
Kiplinger "insights for investors" online, first listed 91 "Top Dividend Stocks From Around The World" 7/13/20. Two recent Kiplinger articles provided 102 Top Dividend Stocks on Earth as of 7/1/21. 39
Now on Sale at Walmart: Insulin That's Cheaper Than Brands from Lilly, Sanofi, or Novo Nordisk
01:06pm, Tuesday, 29'th Jun 2021
The discount chain's private label sells at prices more than 50% lower than brand names made by Lilly, Sanofi, and Novo Nordisk.
Sanofi Invests To Build Internal Capabilities in mRNA
09:09am, Tuesday, 29'th Jun 2021
Sanofi SA (NASDAQ: SNY) is working towards its R&D approach around mRNA to accelerate the development and delivery of next-generation vaccines. The company will invest approximately €400 million p
Sanofi Is Injecting Almost Half A Billion Dollars Each Year Into mRNA Tech Driving Pfizer, Moderna Covid Shots
07:07am, Tuesday, 29'th Jun 2021
The vaccine heavyweight will invest nearly $480 million a year to develop mRNA vaccines for other diseases.
Sanofi Divests 16 Consumer Health Brands To Stada
02:16pm, Monday, 28'th Jun 2021
Amid a reorganization scheme aimed at slashing costs and prioritizing blockbuster immunology Dupixent, Sanofi SA (NASDAQ: SNY) will offload 16 consumer health products to Germany's Stada Arzneimi
Sanofi's Soliqua Shows Improved Blood Sugar Control Without Weigh Gain Against Premixed Insulin
12:40pm, Monday, 28'th Jun 2021
Sanofi SA (NASDAQ: SNY) has announced new study data of Soliqua 100/33 (insulin glargine and lixisenatide injection) that met its two primary endpoints and all key secondary endpoints in a head-to-
Sanofi - Regeneron's Immunotherapy Scores European Approval For Skin And Lung Cancer Settings
08:51am, Friday, 25'th Jun 2021
The European Commission (EC) has approved Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo (cemiplimab) for two additional indications - basal cell carcinoma (BCC
Sanofi (SNY)/Translate Bio Begin Study on mRNA Flu Vaccine
12:02pm, Wednesday, 23'rd Jun 2021
Sanofi (SNY) and Translate Bio begin a phase I study on an mRNA-based vaccine candidate against seasonal influenza.
Sanofi SA (SNY) at Guggenheim Biopharma Strategy Series Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation Conference (Transcript)
Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial
06:32am, Tuesday, 22'nd Jun 2021
Sanofi Pasteur, vaccine unit of Sanofi SA (NASDAQ: SNY) and Translate Bio Inc (NASDAQ: TBIO) have initiated a Phase 1 trial evaluating an mRNA-based investigational vaccine against seasonal infl
Sanofi's (SNY) Aubagio Gets EU Nod for MS in Pediatric Patients
01:32pm, Monday, 21'st Jun 2021
The European Commission approves Sanofi's (SNY) Aubagio for the treatment of pediatric patients aged 10 to 17 years with relapsing-remitting multiple sclerosis.
How This Pharma Company Can Benefit From Its Competitors
05:11am, Sunday, 20'th Jun 2021
Delays in FDA approval for Incyte could spell good news for Sanofi.
Europe Approves Sanofi's Expanded Use Of Aubagio In Pediatric Patients With Multiple Sclerosis
03:27pm, Friday, 18'th Jun 2021
The European Commission has approved Sanofi SA's (NASDAQ: SNY) Aubagio (teriflunomide) for the treatment of pediatric patients 10 to 17 years of age with relapsing-remitting multiple sclerosis (RRM
